Applied Therapeutics (APLT) Competitors $0.40 0.00 (-1.03%) As of 12:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. GOSS, CRGX, KOD, ENGN, SOPH, ELDN, ANNX, IVA, CRDF, and MDWDShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Gossamer Bio (GOSS), CARGO Therapeutics (CRGX), Kodiak Sciences (KOD), enGene (ENGN), SOPHiA GENETICS (SOPH), Eledon Pharmaceuticals (ELDN), Annexon (ANNX), Inventiva (IVA), Cardiff Oncology (CRDF), and MediWound (MDWD). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. Gossamer Bio CARGO Therapeutics Kodiak Sciences enGene SOPHiA GENETICS Eledon Pharmaceuticals Annexon Inventiva Cardiff Oncology MediWound Gossamer Bio (NASDAQ:GOSS) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment. Do analysts recommend GOSS or APLT? Gossamer Bio currently has a consensus price target of $7.50, indicating a potential upside of 638.92%. Applied Therapeutics has a consensus price target of $6.10, indicating a potential upside of 1,406.17%. Given Applied Therapeutics' higher possible upside, analysts clearly believe Applied Therapeutics is more favorable than Gossamer Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gossamer Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor GOSS or APLT? In the previous week, Applied Therapeutics had 1 more articles in the media than Gossamer Bio. MarketBeat recorded 4 mentions for Applied Therapeutics and 3 mentions for Gossamer Bio. Gossamer Bio's average media sentiment score of 1.36 beat Applied Therapeutics' score of 1.18 indicating that Gossamer Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gossamer Bio 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Applied Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in GOSS or APLT? 81.2% of Gossamer Bio shares are owned by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are owned by institutional investors. 5.0% of Gossamer Bio shares are owned by company insiders. Comparatively, 8.6% of Applied Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer GOSS or APLT? Gossamer Bio received 75 more outperform votes than Applied Therapeutics when rated by MarketBeat users. Likewise, 66.81% of users gave Gossamer Bio an outperform vote while only 57.55% of users gave Applied Therapeutics an outperform vote. CompanyUnderperformOutperformGossamer BioOutperform Votes15566.81% Underperform Votes7733.19% Applied TherapeuticsOutperform Votes8057.55% Underperform Votes5942.45% Which has more risk and volatility, GOSS or APLT? Gossamer Bio has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Which has stronger valuation and earnings, GOSS or APLT? Applied Therapeutics has lower revenue, but higher earnings than Gossamer Bio. Gossamer Bio is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGossamer Bio$114.70M2.01-$179.82M-$0.26-3.90Applied Therapeutics$455K126.02-$119.76M-$0.95-0.43 Is GOSS or APLT more profitable? Gossamer Bio's return on equity of -127.28% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Gossamer BioN/A -127.28% -22.12% Applied Therapeutics N/A -260.75%-76.04% SummaryGossamer Bio beats Applied Therapeutics on 9 of the 16 factors compared between the two stocks. Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$57.48M$6.72B$5.49B$7.97BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-0.257.3622.6118.58Price / Sales126.02241.71397.51103.15Price / CashN/A65.8538.1834.62Price / Book-2.036.486.704.26Net Income-$119.76M$143.43M$3.22B$248.31M7 Day Performance1.68%1.69%1.26%1.34%1 Month Performance-11.98%6.58%3.73%3.92%1 Year Performance-90.88%-2.63%15.82%5.33% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics4.0849 of 5 stars$0.41-1.0%$6.10+1,406.2%-90.7%$57.48M$455,000.00-0.2530Upcoming EarningsNews CoveragePositive NewsGOSSGossamer Bio4.0774 of 5 stars$0.92+2.8%$7.50+715.2%+43.7%$209.27M$114.70M-2.88180Upcoming EarningsPositive NewsGap UpCRGXCARGO Therapeutics2.0858 of 5 stars$4.54-0.2%$15.00+230.4%-76.1%$208.57MN/A-1.06116News CoveragePositive NewsKODKodiak Sciences4.0486 of 5 stars$3.94-1.4%$9.00+128.7%+35.8%$208.30MN/A-1.0890News CoverageENGNenGene3.4054 of 5 stars$4.03+1.0%$23.29+477.7%-74.0%$205.49MN/A-6.9531Analyst ForecastShort Interest ↑Gap DownSOPHSOPHiA GENETICS2.36 of 5 stars$3.06flat$6.80+122.2%-40.2%$204.06M$65.17M-2.81520Upcoming EarningsNews CoverageELDNEledon Pharmaceuticals2.18 of 5 stars$3.42+1.8%$12.50+265.6%+32.2%$203.60MN/A-1.6910Upcoming EarningsShort Interest ↑News CoveragePositive NewsANNXAnnexon2.0316 of 5 stars$1.82-0.9%$18.67+923.4%-59.1%$199.12MN/A-1.7360Positive NewsIVAInventiva1.931 of 5 stars$3.79-3.2%$10.40+174.8%+17.1%$198.63M$9.20M0.00100Gap UpCRDFCardiff Oncology1.4697 of 5 stars$2.94-0.2%$11.67+297.5%-37.2%$195.25M$683,000.00-3.1220News CoverageMDWDMediWound1.4396 of 5 stars$18.08+0.6%$31.33+73.3%-4.9%$195.14M$20.22M-6.2380 Related Companies and Tools Related Companies Gossamer Bio Alternatives CARGO Therapeutics Alternatives Kodiak Sciences Alternatives enGene Alternatives SOPHiA GENETICS Alternatives Eledon Pharmaceuticals Alternatives Annexon Alternatives Inventiva Alternatives Cardiff Oncology Alternatives MediWound Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APLT Stock Free APLT Stock Alerts